老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cue Biopharma, Inc.

0.2394
-0.0115-4.58%
盘后：0.2200-0.0194-8.12%18:40 EDT
成交量：114.04万
成交额：26.26万
市值：2,338.00万
市盈率：-0.85
高：0.2417
开：0.2409
低：0.2224
收：0.2509
52周最高：1.05
52周最低：0.2224
股本：9,766.08万
流通股本：9,097.21万
量比：1.31
换手率：1.25%
股息：- -
股息率：- -
每股收益(TTM):-0.2808
每股收益(LYR):-0.2808
净资产收益率：-121.11%
总资产收益率：-44.56%
市净率：0.88
市盈率(LYR):-0.85

数据加载中...

总览公司新闻资讯公告
2020/03/12

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/12

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/10

重要事件披露

Current report, items 1.01, 5.02, and 9.01
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/18

超过5%披露

General statement of acquisition of beneficial ownership
2019/11/26

重要事件披露

Current report, items 1.01, 1.02, and 9.01
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/09

重要事件披露

Current report, item 5.02
2019/10/07

重要事件披露

Current report, items 1.01, 5.02, and 9.01
2019/08/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/06

重要事件披露

Current report, items 5.02 and 5.07
2019/07/09

SEC问询函

[Cover]Correspondence
2019/07/09

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2019/07/09

[修订]季度报告

[Amend] Quarterly report [Sections 13 or 15(d)]
2019/06/25

持股变动声明

Statement of changes in beneficial ownership of securities
更多